Keyphrases
Whole Genome
100%
Pan-cancer Analysis
89%
Tumor
71%
Acute Myeloid Leukemia
69%
Somatic mutation
38%
Human Cancer
37%
In Cancer
34%
Whole Genome Sequencing
33%
DNMT3A
30%
Myelodysplastic Syndrome
30%
Clonal Evolution
25%
Neoantigen
24%
Hematopoietic Cells
23%
Cancer Genome Atlas
21%
Subclone
20%
Clonal Architecture
20%
Tumor Subtype
19%
Cancer Types
18%
Breast Cancer
18%
Germ Cells
18%
Cancer Genome
18%
Tumor Protein p53 (TP53)
18%
Acute Myeloid Leukemia Cells
17%
Tumor Evolution
17%
Structural Variants
15%
Hematopoietic Stem Cells
13%
Glioblastoma
13%
Genome Analysis
12%
Primary Tumor
12%
Single-cell RNA Sequencing (scRNA-seq)
12%
Mitochondrial DNA
12%
Molecular Characterization
12%
Driver mutations
11%
Massively Parallel Sequencing
11%
Mutational Processes
11%
Exome Sequencing
11%
Whole-genome Sequence Data
11%
Leukemia
11%
Metastasis
11%
Tumor Samples
11%
Genomic Characterization
10%
Whole Exome Sequencing
10%
Clonal Hematopoiesis
10%
TP53 mutation
10%
Path Analysis
10%
Immunogenomics
10%
Genomic Analysis
9%
RNA Sequencing (RNA-seq)
9%
Secondary Acute Myeloid Leukemia (sAML)
9%
DNA Methylation (DNAm)
9%
Biochemistry, Genetics and Molecular Biology
Genomics
87%
Myeloid
86%
Whole Genome Sequencing
43%
Somatic Mutation
43%
Pan-cancer
39%
Hematopoietic Cell
33%
Clonal Evolution
25%
Deep Sequencing
24%
Germ Cell
23%
Genetics
23%
Exome Sequencing
22%
Germline
20%
Exome
20%
DNMT3A
20%
Gene Mutation
20%
DNA Methylation
19%
RNA Sequence
18%
Cancer Cell
18%
Hematopoiesis
17%
Carcinogenesis
15%
Mutated Genes
14%
Gene Expression
12%
Gene Frequency
11%
Promoter Region
11%
Progenitor Cell
11%
Estrogen Receptor
11%
Epigenetics
11%
Point Mutation
10%
Immunity
10%
Transcriptome
10%
DNA Methyltransferase
9%
DNA Sequence
9%
Tumor Suppressor Protein
9%
Allele
9%
Methylation
9%
Single-Nucleotide Polymorphism
9%
Messenger RNA
9%
Proteomics
8%
Aromatase Inhibitor
8%
Cytogenetics
8%
Polymorphonuclear Cell
8%
Oncogene
7%
Bisulfite Sequencing
7%
Alpha Thalassemia/Mental Retardation X-Linked
7%
Evolution
7%
Wild Type
7%
Overall Survival
7%
Genome Sequencing
7%
RNA Sequencing
7%
Tumor Progression
6%
